Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine
- PMID: 14407465
Item in Clipboard
Antitumor principles derived from Vinca rosea Linn. I. Vincaleukoblastine and leurosine
Cancer Res.
1960 Aug.
No abstract available
Similar articles
-
STUDIES ON CATHARANTHUS ALKALOIDS. 3. SEPARATION OF VINCALEUKOBLASTINE, LEUROCRISTINE, LEUROSINE AND LEUROSIDINE BY THIN-LAYER CHROMATOGRAPHY.J Chromatogr. 1965 Apr;18:184-8. doi: 10.1016/s0021-9673(01)80346-0. J Chromatogr. 1965. PMID: 14334202 No abstract available.
-
Clinical trials with leurosine methiodide, an alkaloid from Vinca rosea Linn.Cancer Chemother Rep. 1963 Apr;28:53-5. Cancer Chemother Rep. 1963. PMID: 13963767 No abstract available.
-
Some biological effects of Vincaleukoblastine, an alkaloid in Vinca rosea Linn in patients with malignant disease.Cancer Res. 1960 Aug;20:1032-40. Cancer Res. 1960. PMID: 13842983 No abstract available.
-
[ANTINEOPLASTIC ALKALOIDS OF VINCA ROSEA LINN. (REVIEW OF THE LITERATURE)].Probl Gematol Pereliv Krovi. 1964 Dec;9:26-33. Probl Gematol Pereliv Krovi. 1964. PMID: 14312105 Review. Russian. No abstract available.
-
[Pharmacology of Catharanthus alkaloids].Bull Cancer. 1996 Mar;83(3):176-86. Bull Cancer. 1996. PMID: 8695919 Review. French.
Cited by
-
Vinca alkaloids as a potential cancer therapeutics: recent update and future challenges.3 Biotech. 2023 Jun;13(6):211. doi: 10.1007/s13205-023-03636-6. Epub 2023 May 24. 3 Biotech. 2023. PMID: 37251731 Review.
-
Alkaloid from Alstonia yunnanensis diels root against gastrointestinal cancer: Acetoxytabernosine inhibits apoptosis in hepatocellular carcinoma cells.Front Pharmacol. 2023 Jan 11;13:1085309. doi: 10.3389/fphar.2022.1085309. eCollection 2022. Front Pharmacol. 2023. PMID: 36712668 Free PMC article.
-
A Review on Mechanistic Insight of Plant Derived Anticancer Bioactive Phytocompounds and Their Structure Activity Relationship.Molecules. 2022 May 9;27(9):3036. doi: 10.3390/molecules27093036. Molecules. 2022. PMID: 35566385 Free PMC article. Review.
-
Microtubule Targeting Agents in Disease: Classic Drugs, Novel Roles.Cancers (Basel). 2021 Nov 12;13(22):5650. doi: 10.3390/cancers13225650. Cancers (Basel). 2021. PMID: 34830812 Free PMC article. Review.
-
Erythrocytes as Carriers: From Drug Delivery to Biosensors.Pharmaceutics. 2020 Mar 18;12(3):276. doi: 10.3390/pharmaceutics12030276. Pharmaceutics. 2020. PMID: 32197542 Free PMC article. Review.